3,107 research outputs found

    MEASURING IRRATIONAL BELIEFS AMONG YOUTH: DEVELOPMENT OF THE CHILDREN’S IRRATIONAL RESPONSE CHECKLIST

    Get PDF
    Cognitive Behavioral Therapy (CBT) and Rational Emotive Behavior Therapy (REBT) are evidenced-based approaches that have been identified as effective for the treatment of psychological disorders among youth (Bernard & Terjesen, 2020). However, although beliefs and cognitions have been shown to be predictive of emotional and behavioral problems in children (MogoaƟe, Podină, et al., 2013), and modifications in cognitions have been shown to be vital for treatment (David et al., 2017), the research and psychometric properties surrounding measures designed to speciïŹcally assess irrational beliefs, self-statements, or automatic thoughts in youth are lacking due to theoretical and practical limitations (Terjesen et al., 2020). The aim of the present study was to address the aforementioned concerns in the measurement research by validating a new self-report measure of irrational beliefs designed for children ages 8 to 11 years old which assesses multidimensional responses to different realistic situational vignettes and is based on the REBT conceptualization of irrationality: The Children’s Irrational Response Checklist (CIRCL). Results showed partial support of the proposed hypotheses within one of the three sample groups including adequate predictive, convergent, and discriminant validity as well as moderate to strong correlates between the CIRCL and other established measures of beliefs (e.g., Child and Adolescent Scale of Irrationality [CASI], Children\u27s Automatic Thoughts Scale [CATS]) and social-emotional functioning (Behavior Assessment System for Children, Third Edition [BASC-3]). These preliminary results add to the limited research within this area, provide promising areas for future research, and have important clinical implications for assessing and treating irrationality among youth

    Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas

    Get PDF
    Retinal hemangioblastomas are the most common manifestation of Von Hippel-Lindau (VHL) disease [1-3]. While peripheral retinal hemangioblastomas may be treated by thermal laser treatment or cryotherapy, optic nerve and macular lesions are more difficult to treat [4, 5]. Based on the theoretical benefit of administering anti-VEGF treatment, intra-vitreally administered bevacizumab (Avastin, a general pan-VEGF inhibitor) is attractive [6, 7]

    Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children

    Get PDF
    Background: Whether long coronavirus disease pertains to children as well is not yet clear. Methods: The authors performed a survey in children suffering from persistent symptoms since initial infection. A total of 510 children infected between January 2020 and January 2021 were included. Results: Symptoms such as fatigue, headache, muscle and joint pain, rashes and heart palpitations and issues such as lack of concentration and short-term memory problems were particularly frequent and confirm previous observations, suggesting that they may characterize this condition. Conclusion: A better comprehension of long coronavirus disease is urgently needed

    Exponential stability of the wave equation with memory and time delay

    Full text link
    We study the asymptotic behaviour of the wave equation with viscoelastic damping in presence of a time-delayed damping. We prove exponential stability if the amplitude of the time delay term is small enough

    Highlights of recent progress in plant lipid research

    Get PDF
    Raw fossil material reserves are not inexhaustible and as prices continue to raise it is necessary to find new sources of alternative and renewable energy. Oils from oleaginous field crops (sunflower and rape) with properties close to those of fossil fuel could constitute an alternative source of energy for the production of raw materials. This is the context in which the 18th International Symposium on Plant lipids (ISPL) was held in Bordeaux from 20th to 25th July 2008 at “La CitĂ© Mondiale”. The 18th ISPL gathered 270 researchers from 33 countries. Sixty nine oral communications and 136 posters were presented during the 12 sessions of the Symposium. The sessions have covered all the different aspects of the Plant Lipid field including: Surface lipids: suberin, cutin and waxes, Fatty acids, Glycerolipids, Plant lipids as renewable sources of energy, Seed oils and bioengineering of metabolic pathways, Lipid catabolism, Models for lipid studies: lower plants, micro-organisms and others, Modifications of proteins by lipids, Sphingolipids, sterols and isoprenoids, Lipid signaling and plant stress responses, Lipid trafficking and membrane dynamics, New methods and technologies: functional lipidomics, fluxome, modelling

    Assessing the representation of species included within the Canadian Living Planet Index

    Get PDF
    To effectively combat the biodiversity crisis, we need ambitious targets and reliable indicators to accurately track trends and measure conservation impact. In Canada, the Living Planet Index (LPI) has been adapted to produce a national indicator by both World Wildlife Fund-Canada (Canadian Living Planet Index; C-LPI) and Environment and Climate Change Canada (Canadian Species Index) to provide insight into the status of Canadian wildlife, by evaluating temporal trends in vertebrate population abundance. The indicator includes data for just over 50% of Canadian vertebrate species. To assess whether the current dataset is representative of the distribution of life history characteristics of Canadian wildlife, we analyzed the representation of species-specific biotic variables (i.e., body size, trophic level, lifespan) for vertebrates within the C-LPI compared to native vertebrates lacking LPI data. Generally, there was considerable overlap in the distribution of biotic variables for species in the C-LPI compared to native Canadian vertebrate species lacking LPI data. Nevertheless, some differences among distributions were found, driven in large part by discrepancy in the representation of fishes—where the C-LPI included larger-bodied and longer-lived species. We provide recommendations for targeted data collection and additional analyses to further strengthen the applicability, accuracy, and representativity of biodiversity indicators

    A Parameter Study of Type II Supernova Light Curves Using 6 M_odot He Cores

    Full text link
    Results of numerical calculations of Type II supernova light curves are presented. The model progenitor stars have 6 M⊙M{_\odot} cores and various envelopes, originating from a numerically evolved 20 M⊙M{_\odot} star. Five parameters that affect the light curves are examined: the ejected mass, the progenitor radius, the explosion energy, the 56^{56}Ni mass, and the extent of 56^{56}Ni mixing. The following affects have been found: 1) the larger the progenitor radius the brighter the early--time light curve, with little affect on the late--time light curve, 2) the larger the envelope mass the fainter the early light curve and the flatter the slope of the late light curve, 3) the larger the explosion energy the brighter the early light curve and the steeper the slope of the late light curve, 4) the larger the 56^{56}Ni mass the brighter the overall light curve after 20 to 50 days, with no affect on the early light curve, 5) the more extensive the 56^{56}Ni mixing the brighter the early light curve and the steeper the late light curve. The primary parameters affecting the light curve shape are the progenitor radius and the ejected mass. The secondary parameters are the explosion energy, 56^{56}Ni mass and 56^{56}Ni mixing. I find that while in principle the general shape and absolute magnitude of a light curve indicate a unique set of parameters, in practice it is difficult to avoid some ambiguity in the parameters. I find that the nickel--powered diffusion wave and the recombination of helium produce a prominent secondary peak in all our calculations. The feature is less prominent when compositional mixing, both 56^{56}Ni mixing and mixing between the hydrogen and helium layers, occurs. The model photospheric temperatures and velocities are presented, for comparison to observation.Comment: 39 pages, 15 figures. Astrophysical Journal (Accepted, Dec. 20, 2004

    Compliance with evidence-based clinical guidelines in the management of acute biliary pancreatitis: the MANCTRA-1 study protocol

    Get PDF
    Despite existing evidence-based practice guidelines for the management of biliary acute pancreatitis (AP), the clinical compliance with recommendations is overall poor. Studies in this field have identified significant discrepancies between evidence-based recommendations and daily clinical practice. The most commonly reported gaps between clinical practice and AP guidelines include the indications for CT scan, need and timing of artificial nutritional support, indications for antibiotics, and surgical/endoscopic management of biliary AP. The MANCTRA-1 (coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis) study is aiming to identify the areas for quality improvement that will require new implementation strategies. The study primary objective is to evaluate which items of the current AP guidelines are commonly disregarded and if they correlate with negative clinical outcomes according to the different clinical presentations of the disease. We attempt to summarize the main areas of sub-optimal care due to the lack of compliance with current guidelines to provide the basis for introducing a number of bundles in AP patients' management to be implemented during the next years. The MANCTRA-1 study is an international multicenter, retrospective cohort study with the purpose to assess the outcomes of patients admitted to hospital with a diagnosis of biliary AP and the compliance of surgeons worldwide to the most up-to-dated international guidelines on biliary AP. ClinicalTrials.Gov ID Number: NCT04747990, Date: February 23, 2021. Protocol Version V2.2
    • 

    corecore